Aktie A2P1QG ATOMO DIAGNOSTICS LIMITED
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Atomo Diagnostics Limited

Aktien

A2P1QG

AU0000080327

AT1

Markt geschlossen - Australian S.E.
Andere Börsenplätze
 08:10:11 03.05.2024 		% 5 Tage % 1. Jan.
0.031 AUD +3.33% Intraday Chart für Atomo Diagnostics Limited +3.33% +40.91%
30.04. Transcript : Atomo Diagnostics Limited, Q3 2024 Earnings Call, Apr 30, 2024
06.03. Atomo Diagnostics erhält Auftrag zur Lieferung von HIV-Selbsttests im Wert von AU$970,000 MT

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Atomo Diagnostics Wins AU$570,000 HIV Self-Tests Order
Atomo Diagnostics Wins Order to Supply AU$970,000 Worth of HIV Self-Tests
Atomo Diagnostics Limited Reports Earnings Results for the Half Year Ended December 31, 2023
Atomo Diagnostics Limited Announces the Resignation of Curt LaBelle as Non-Executive Director
Actinogen Medical Names CFO
Atomo Diagnostics CFO to Step Down
Atomo Diagnostics Limited Announces the Departure of William Souter as Chief Financial Officer, Effective 13 December 2023
Atomo Diagnostics Expands Footprint of HIV Self-Test Kit
Seattle-based startup makes 'beanless coffee' to help combat deforestation
Atomo Diagnostics Limited Reports Earnings Results for the Full Year Ended June 30, 2023
Atomo Diagnostics Raises AU$2.3 Million Via Placement, Share Purchase Plan
Atomo Diagnostics Raising AU$4 Million Via Placement, Share Purchase Plan
Atomo Diagnostics Signs Deal to Supply HIV Tests to Europe
Atomo Diagnostics Secures Nearly $2 Million Supply Deal for HIV Self-Test in South Africa
Atomo Diagnostics Secures AU$900,000 HIV Self-Tests Order
Atomo Diagnostics Limited Announces Significant Purchase Order for HIV Self-Tests for Europe
Atomo Diagnostics Limited Reports Earnings Results for the Half Year Ended December 31, 2022
Atomo Diagnostics Limited Announces Change of Company Secretary, Effective March 1, 2023
Atomo Diagnostics, NG Biotech Sign Commercialization Deal for Rapid Blood-based Pregnancy Tests; Shares Jump 4%
Atomo Diagnostics Limited and NG Biotech Sign New Commercialisation Agreement to Expand the Launch of A Unique Blood Based Rapid Pregnancy Test in Key Global Markets
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2P1QG Aktie
  4. Nachrichten Atomo Diagnostics Limited
  5. Andere Sprachen